GENEVA, March 31 -- XELLSMART BIO-PHARMACEUTICAL (SUZHOU) CO., LTD. (Unit 201, Building 3, Zone B, Biomedical Industrial Park Phase 3, 99 Jingu Road, Suzhou Industrial ParkSuzhou, Jiangsu 215332), 士泽生物医药(苏州)有限公司 (中国江苏省苏州市苏州工业园区金谷路99号生物医药产业园三期B区项目3号楼201单元) filed a patent application (PCT/CN2024/120109) for "LOW-IMMUNOGENICITY CELL EXPRESSING MCL1 AND PREPARATION METHOD THEREFOR" on Sep 20, 2024. With publication...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.